Launch of first veterinary vaccines produced in China

Boehringer Ingelheim launches first veterinary vaccines produced in ChinaThe first local manufacturing plant, wholly-owned by a multinational animal health company, focuses on the China swine marketThe Taizhou plant will produce PRRS vaccines and supply them locallyThe company delivers on its long-term ‘in China, for China’ commitment while accelerating its localisation strategy
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news